BrainSpec University of Minnesota MR Spectroscopy Research
- BrainSpec is collaborating with the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota to bring a new level of automation to magnetic resonance (MR) spectroscopy.
- The core of this collaboration is AutoVOI, a system developed by the spectroscopy division at CMRR.
- By automating this step, AutoVOI substantially reduces this variability, leading to more consistent and reliable results.
BrainSpec and University of Minnesota Partner to Advance MR Spectroscopy
Table of Contents
BrainSpec is collaborating with the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota to bring a new level of automation to magnetic resonance (MR) spectroscopy. This partnership, formalized through an exclusive license agreement managed by University of Minnesota Technology Commercialization, aims to broaden access to this powerful neuroimaging technique.
Automating Brain Region Selection with AutoVOI
The core of this collaboration is AutoVOI, a system developed by the spectroscopy division at CMRR. AutoVOI automates the often-complex process of selecting specific brain regions for MR spectroscopy analysis. Traditionally, this selection is a manual process, introducing potential variability between different scans and even between different users performing the analysis.
By automating this step, AutoVOI substantially reduces this variability, leading to more consistent and reliable results. This is crucial for large-scale research projects and multi-center studies where data needs to be comparable across different sites.
![Conceptual illustration of AutoVOI selecting brain regions. [placeholder for actual image]](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAUAAAAFCAYAAACNbyblAAAAHElEQVQI12P4//8/w+n8AAAAASUVORK5CYII= "BrainSpec University of Minnesota MR Spectroscopy Research")
Simplifying MR Spectroscopy for Wider Adoption
BrainSpec intends to leverage this technology to simplify MR spectroscopy, making it more accessible to a wider range of researchers. The company recognizes that the technical complexity of the technique can be a barrier to entry for many labs. autovoi addresses this challenge by streamlining a critical step in the process.
According to BrainSpec, this increased accessibility will ultimately accelerate research in a variety of neurological fields. The automation provided by AutoVOI allows researchers to focus on data interpretation and scientific discovery, rather than being bogged down in the technical details of scan setup and region selection.
We believe AutoVOI has the potential to transform MR spectroscopy research by reducing technical barriers and enabling more widespread adoption of this valuable technique.
Looking Ahead
This collaboration represents a notable step forward in the field of neuroimaging. as of september 4, 2025, BrainSpec is actively working to integrate AutoVOI into its existing product line and make it available to researchers worldwide. The University of Minnesota’s commitment to technology commercialization, through its Technology Commercialization office, played a vital role in bringing this innovation to market.